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ABSTRACT
In mammalian cells, distinct H3K4 methylation states
are created by deposition of methyl groups by mul-
tiple complexes of histone lysine methyltransferase
2 (KMT2) family proteins. For comprehensive anal-
yses that directly compare the catalytic properties
of all six human KMT2 complexes, we employed a
biochemically defined system reconstituted with re-
combinant KMT2 core complexes (KMT2CoreCs) con-
taining minimal components required for nucleoso-
mal H3K4 methylation activity. We found that each
KMT2CoreC generates distinct states and different
levels of H3K4 methylation, and except for MLL3 all
are stimulated by H2Bub. Notably, SET1BCoreC ex-
hibited the strongest H3K4 methylation activity and,
to our surprise, did not require H2B ubiquitylation
(H2Bub); in contrast, H2Bub was required for the
H3K4me2/3 activity of the paralog SET1ACoreC. We
also found that WDR5, RbBP5, ASH2L and DPY30 are
required for efficient H3K4 methyltransferase activi-
ties of all KMT2CoreCs except MLL3, which could pro-
duce H3K4me1 in the absence of WDR5. Importantly,
deletion of the PHD2 domain of CFP1 led to complete
loss of the H3K4me2/3 activities of SET1A/BCoreCs
in the presence of H2Bub, indicating a critical role for
this domain in the H2Bub-stimulated H3K4 methyla-
tion. Collectively, our results suggest that each KMT2
complex methylates H3K4 through distinct mecha-
nisms in which individual subunits differentially par-
ticipate.
INTRODUCTION
Histone H3 lysine 4 (H3K4) methylation plays an impor-
tant role in many cellular processes, such as transcription
and DNA replication, repair and recombination, that are all
central to cell growth, differentiation and development (1–
3). The association of impaired H3K4 methylation with var-
ious human diseases, including developmental defects and
cancers (4–7), has motivated intense efforts to understand
the precise roles of this histone modification in regulating
cellular events.
H3K4 methylation can be present in three states:
mono-methylated (H3K4me1), di-methylated (H3K4me2),
and tri-methylated (H3K4me3). In mammalian cells,
H3K4 methylation is mediated by at least six SET
domain-containing KMT2 (lysine methyltransferase 2)
family proteins––SET1A/KMT2F, SET1B/KMT2G,
MLL1/KMT2A, MLL2/KMT2B, MLL3/KMT2C, and
MLL4/KMT2D––each of which forms a multimeric
complex (hereafter, KMT2 complex) with several subunits
common to all complexes (e.g., WDR5, RbBP5, ASH2L,
and DPY30) as well as some that are unique to each
complex (7). The roles of individual KMT2 complexes in
transcriptional regulation have been extensively studied.
Preferential co-localization of SET1A with H3K4me3
at promoter regions of highly expressed genes supports
a general regulatory role for the SET1A complex in
transcriptional activation (8). MLL1 and MLL2 are re-
ported to control hematopoietic development by inducing
H3K4me3 at the promoter regions of Hox gene clusters
through selective recruitment to these genes (9,10). For
MLL2 specifically, it has been shown that MLL2-mediated
H3K4me3 on bivalent promoters is critical for the precise
differentiation of stem cells (11,12). In addition, MLL3
and MLL4 deposit H3K4me1 at enhancers involved in cell
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type-specific gene expression (13–15). Thus, despite having
an identical target site on histone H3, these complexes are
not redundant, marking methylations at different locations
in their specific target genes and producing different
methylation states, which in turn recruit distinct effector
molecules (1,8).
Interestingly, early yeast genetic studies found that mono-
ubiquitylation of histone H2B (H2Bub) at lysine 123 is
a prerequisite for H3K4 methylation (16,17). Subsequent
biochemical analyses using purified factors clearly demon-
strated that H2Bub directly stimulates H3K4 methylation
mediated by the yeast Set1 complex (18) and human SET1A
complex (19). Recent studies have unveiled the mechanis-
tic basis of this histone crosstalk in the yeast Set1 com-
plex, showing that it involves H2Bub-induced conforma-
tional changes in the complex that support H3K4 methy-
lation activity (20–22).
Compared with cellular functions of KMT2 proteins,
which have been extensively investigated, our understand-
ing of the catalytic properties of human KMT2 complexes,
including their relative H3K4 methylation activities and as-
sociated H2Bub requirements for enzymatic activity, is lim-
ited. Here, using a biochemically defined system employing
recombinant KMT2 complexes and chromatin templates,
we performed comprehensive and comparative biochemi-
cal analyses to characterize H3K4 methyltransferase activ-
ities of human KMT2 complexes. Our studies revealed that
the H3K4 methylation activities of all KMT2 complexes ex-
cept MLL3 are stimulated by H2Bub. We further found that
KMT2 complexes generate different levels of distinct H3K4
methylation states and have distinct subunit requirements
for their catalytic activities, suggesting that distinct mecha-
nistic pathways govern H3K4 methylation processes among
KMT2 complexes.
MATERIALS AND METHODS
Construction of plasmids and baculoviruses, and purification
of recombinant proteins and human KMT2 family complexes
For baculovirus-mediated expression, cDNAs were sub-
cloned into pFASTBAC1 (Gibco-Invitrogen), with or with-
out an epitope, and baculoviruses were generated accord-
ing to the manufacturer’s instructions (Gibco-Invitrogen).
For reconstitution of complexes containing FLAG-tagged
KMT2 family protein fragments, Sf9 cells were infected
with combinations of baculoviruses, and complexes were
affinity purified on M2 agarose (Sigma) as described
(23). For plasmid transfection-mediated expression, cD-
NAs encoding N-terminally FLAG-tagged, full-length hu-
man KMT2 family proteins and cDNAs encoding un-
tagged KMT2 family complex subunits were subcloned into
pVLAD6 (Addgene) (24). HEK293E cells (∼1.5 × 106/ml)
in suspension culture (300 ml) were transfected with com-
binations of expression plasmid (150 g each) using the
polyethylenimine (PEI; Sigma) method. After 60 h, cells
were treated with 2 M bortezomib (Millipore) and incu-
bated for an additional 12 h. Cells were washed once with
phosphate-buffered saline (PBS) and then with five packed-
cell volumes (PCVs) of hypotonic buffer (10 mM Tris–HCl
[pH 7.4], 10 mM KCl, and 1.5 mM MgCl2) each, after which
they were resuspended in 2 PCVs of hypotonic buffer and
incubated for 10 min. Swollen cells were disrupted with a
Dounce homogenizer (pestle B, 15 strokes) and centrifuged
at 3,900 rpm for 10 min. Nuclear pellets were resuspended
in 10 ml extraction buffer (10 mM Tris–HCl [pH 7.9], 300
mM NaCl, 3 mM MgCl2, 1 mM EGTA, 0.5% Triton X-
100, 1 mM PMSF, 2 mM DTT and protease inhibitor cock-
tail [Roche]), minced with a Dounce homogenizer (pestle B,
3 rounds of 10 strokes at 10 min intervals), and then cen-
trifuged at 18,000 rpm for 20 min. Clarified extracts were
incubated with 80 l of M2 agarose for 4 h. After exten-
sive washing with wash buffer (20 mM Tris–HCl [pH 7.9],
200 mM NaCl, 2 mM MgCl2, 0.2 mM EDTA, 15% glyc-
erol, 0.1% NP40, 1 mM PMSF and 1 mM DTT), complexes
were eluted with wash buffer containing 0.25 mg/ml FLAG
peptide. The expression and purification of recombinant
Xenopus histones, semi-synthetic H2Bub, histone octamers,
NAP1 and the ACF complex were as described (23,25).
In vitro chromatin assembly
Procedures for chromatin assembly using the recombinant
ACF/NAP1 system were as described (23). Briefly, 700 ng
core histone octamer and 2.4 g NAP1 in 55 l HEG buffer
(25 mM HEPES [pH 7.6], 0.1 mM EDTA and 10% glycerol)
were incubated on ice for 30 min. After addition of 160 ng
ACF complex and 700 ng p53ML plasmid (26), the reaction
was adjusted to 25 mM HEPES [pH 7.6], 50 mM KCl, 5 mM
MgCl2, 0.1 mM EDTA, 10% glycerol and 3.2 mM ATP in
a final volume of 70 l, and incubated at 27◦C for 4 h.
In vitro histone methyltransferase assays
For free histone H3 methyltransferase assays, reactions con-
taining 100 ng recombinant histone H3 and the indicated
concentration of purified KMT2 complex in 20 l reaction
buffer (25 mM HEPES [pH 7.6], 50 mM KCl, 5 mM MgCl2,
0.1 mM EDTA, and 10% glycerol) supplemented with 100
M SAM (S-adenosyl methionine; NEB) were incubated at
30◦C for 1 h. For recombinant chromatin methyltransferase
assays, reactions containing 250 ng (histone amount) re-
combinant chromatin, the indicated concentration of puri-
fied KMT2 complex and 100 M SAM were adjusted to 50
l with HEG buffer, and incubated at 30◦C for 1 h. Proteins
were resolved by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and subjected to immunoblot
analyses.
Antibodies
Polyclonal anti-SET1A and anti-DPY30 antibodies were
developed against purified histidine-tagged human SET1A
fragment (amino acid residues 358–477) and human DPY-
30 (full-length) proteins, respectively, and affinity purified
(AbClon). Polyclonal anti-CFP1 and anti-WDR82 anti-
bodies were obtained from the Roeder laboratory. Poly-
clonal anti-WDR5 antibody was obtained from the Allis
laboratory. The following antibodies were obtained com-
mercially: anti-SET1B (A302-281A), anti-MLL2 (A300-
113A), anti-RbBP5 (A300-109A), anti-ASH2L (A300-
489A), and anti-Menin (A300-105A) from Bethyl Labo-
ratories; anti-WDR5 (ab22512), anti-H3 (ab1791), anti-
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H3K4me1 (ab8895), and anti-H3K4me2 (ab7766) from Ab-
cam; anti-H3K4me3 (AM39159) from Active Motif; and
anti-FLAG (A8592) from Sigma.
RESULTS
H2B ubiquitylation directly stimulates H3K4 methylation ac-
tivities of human KMT2Core complexes
The large size of catalytic/scaffold KMT2 family proteins
has been a major obstacle for purification of KMT2 com-
plexes to homogeneity. In addition to a catalytic SET
domain-containing KMT2 protein and the associating
common subunits, WDR5, RbBP5, ASH2L and DPY30,
collectively referred to a ‘WRAD’, each KMT2 family com-
plex also has unique subunits that may differentially af-
fect H3K4 methylation activities. Therefore, for compar-
ative biochemical analyses of intrinsic enzyme activities
of all six human KMT2 complexes, we sought to iden-
tify domains and subunits that are minimally required for
H3K4 methyltransferase activities. In this context, we pre-
viously demonstrated that a partial yeast Set1 complex
(C762 complex) composed of a Set1 fragment (residues
762–1080) encompassing the n-SET, SET and post-SET
domains together with five associating subunits, Swd3 (a
homolog of mammalian WDR5), Swd1 (RbBP5), Bre2
(ASH2L), Sdc1 (DPY30) and Spp1 (CFP1), exhibits robust
H2B ubiquitylation-dependent H3K4 methylation activity
toward chromatin substrates (18,21).
Accordingly, we reconstituted partial human KMT2 core
complexes (hereafter, KMT2CoreCs) corresponding to the
yeast C762 Set1 complex and affinity purified them from Sf9
insect cells infected with baculoviruses expressing FLAG-
KMT2Core protein fragments (encompassing n-SET, SET
and post-SET domains for SET1A/B, and pre-SET, SET
and post-SET domains for MLL1/2/3/4) and five untagged
subunits (WRAD and CFP1) (Figure 1A). All WRAD sub-
units were stably integrated into all purified complexes, but
CFP1 was found only in SET1ACoreC and SET1BCoreC
(Figure 1B), confirming SET1A- and SET1B-specific asso-
ciation of CFP1 (27,28) through the interaction with n-SET
domains, similar to the case for the yeast Set1 complex (18).
In vitro histone methyltransferase (HMT) assays using
free histone H3 (H3) as the substrate revealed that all puri-
fied KMT2CoreCs, except MLL3CoreC, are able to generate
all three H3K4 methylation states; for MLL3CoreC, activ-
ity was restricted to H3K4me1 and H3K4me2 (Figure 1C).
Notably, SET1BCoreC exhibited the strongest H3K4me3
activity (Figure 1C, lane 2), whereas the overall H3K4
methylation activity of SET1ACoreC was weakest among the
tested complexes (Figure 1C, lane 1).
We next tested the H3K4 methylation activity of
complexes towards more physiologically relevant chro-
matin templates containing either unmodified histone H2B
(H2B) or mono-ubiquitylated H2B at lysine 120 (H2Bub)
(25). Consistent with its weak activity towards free H3,
SET1ACoreC showed weak H3K4 methylation activity that
was detectable in immunoblots only after prolonged expo-
sure (Figure 1D, lanes 1 and 2) or in reactions with a high
concentration of the complex (Supplementary Figure S1A).
More importantly, SET1ACoreC–generated H3K4me2/3
exhibited H2Bub dependence. Consistent with its strong
activity towards free H3, SET1BCoreC generated all three
H3K4 methylation states at the highest levels among the
tested complexes (Figure 1D, lanes 3 and 4). In vitro
HMT assays using the complexes further purified by Su-
perose 6 size exclusion chromatography also revealed that
SET1BCoreC exhibited much stronger H3K4 methylation
activities than SET1ACoreC (Supplementary Figure S2).
Although H2Bub increased the H3K4 methylation activ-
ity of SET1BCoreC at all tested concentrations (Supple-
mentary Figure S1B), we found that, in clear contrast to
SET1ACoreC (Figure 1E), SET1BCoreC generated H3K4
methylation even in the absence of H2Bub. This suggests
that, despite having a domain and subunit compositions
similar to that of the SET1A complex and yeast Set1 com-
plex, the SET1B complex is able to bypass the requirement
of H2Bub for H3K4 methylation because of its strong in-
trinsic methyltransferase activity. We also found that both
MLL1CoreC and MLL2CoreC were able to generate all three
H3K4 methylation states, activities that were stimulated, al-
beit modestly, by H2Bub (Figure 1D, lanes 5–8, Supplemen-
tary Figure S1C and D). The chromatin H3K4 methylation
activity of MLL3CoreC was very weak compared with that
of other complexes and was restricted to H3K4me1 (Figure
1D, lanes 9 and 10, Supplementary Figure S1E). H2Bub-
mediated stimulation of MLL3CoreC activity was not clearly
observed, but this could be because the intrinsic H3K4me1
activity of MLL3CoreC is too weak to allow possible H2Bub
stimulatory effects to be monitored by immunoblot analy-
sis. This interpretation is in line with the results of a pre-
vious study using an alternative luminescent method that
showed that H2Bub stimulated the H3K4me1 activity of
a partial MLL3 complex (29). Lastly, MLL4CoreC exhib-
ited mainly H3K4me1/2 activities that were stimulated by
H2Bub; however, the stimulatory effect of H2Bub was mod-
est, requiring longer exposure of immunoblots (Figure 1D,
lanes 11 and 12) or reactions with a higher concentration of
the complex (Supplementary Figure S1F) to be detectable.
Collectively, our biochemical analyses demonstrate that all
KMT2Core complexes have distinctive H3K4 methyltrans-
ferase properties, with different strengths of activity and
methylation species produced, but they were stimulated to
varying degrees by the presence of H2Bub on the chromatin.
Thus, these observations suggest that a common compo-
nent(s) in KMT2 family complexes might be responsible
for their sensitivity to H2Bub-stimulated H3K4 methyla-
tion (see Discussion).
Human SET1ACore and SET1BCore complexes exhibit dis-
tinctive subunit requirements for H3K4 methylation activities
Given our ability to reconstitute catalytically active
KMT2Core complexes, we next sought to establish the re-
quirements of individual subunits within each KMT2CoreC
for H3K4 methylation activity. To this end, we first re-
constituted and affinity-purified SET1ACore and SET1BCore
complexes lacking individual subunits. Yields of purified
complexes obtained in the absence of WDR5, RbBP5 or
ASH2L were significantly lower, suggesting contributions
of these subunits to the efficient formation and stability of
SET1ACoreC (Figure 2A, lanes 3–5) and SET1BCoreC (Sup-
plementary Figure S3A). This conclusion is further sup-
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Figure 1. H3K4 methylation activities of human KMT2Core complexes. (A) A schematic diagram of KMT2Core fragments used for the reconstitution of
complexes and subunit associations deduced from (B). The n-SET, pre-SET, SET and post-SET (hatched box) domains and Win (red box) motif within each
KMT2 protein are depicted. Numbers indicate amino acid residues of each protein. DPY30(×2) indicates the dimeric association of DPY30, which was
established in recent structural analyses of KMT2 complexes (29,31,32). (B) SDS-PAGE/Coomassie blue staining (left) and immunoblot analyses (right)
of purified KMT2Core complexes reconstituted with baculoviruses expressing FLAG-tagged KMT2Core protein (A), WDR5, RbBP5, ASH2L, DPY30 and
CFP1. KMT2Core proteins are marked by asterisks. Note that an insect protein contaminant around 100 kDa (marked by dots) was found sometimes in the
complexes prepared by single-step affinity purification and became more prominent when a large volume of samples (due to low concentration) was loaded.
This protein could be removed by gel filtration and did not affect the H3K4 methylation activities of the affinity-purified complexes as demonstrated in
several KMT2Core complexes (see Supplementary Figures). (C) Differential H3K4 methylation activities of KMT2Core complexes towards free histone H3
(H3) substrate. H3 was subjected to in vitro HMT assays with the indicated KMT2core complexes (7.5 nM). (D and E) Differential H3K4 methylation
activities of KMT2core complexes towards chromatin substrates. Recombinant chromatin templates assembled with unmodified histone H2B (unmod)- or
mono-ubiquitylated H2B at lysine 120 (H2Bub)-containing octamers were subjected to in vitro HMT assays with the indicated KMT2Core complexes at
a concentration of 5 nM (D) or with the indicated concentrations of SET1ACore and SET1BCore complexes (E). H3K4 methylation status was monitored
by immunoblotting with the indicated antibodies in this and other figures. Abbreviations: unmod, unmodified histone H2B; H2Bub, K120-ubiquitylated
H2B; H3K4me1, K4-monomethylated H3; H3K4me2, K4-dimethylated H3; H3K4me3, K4-trimethylated H3.
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Figure 2. Subunit requirements for H3K4 methylation activities of human SET1ACore and SET1BCore complexes. (A) SDS-PAGE/Coomassie blue staining
of purified SET1ACore complexes reconstituted with baculoviruses in the absence of the indicated subunits. Sample loadings were normalized to FLAG-
KMT2Core proteins in this and other figures. Note that because of inefficient complex formation (∼10–20-fold lower concentration compared with the
intact complex), 5- and 2.5-fold lower amounts (maximum loading volumes) of RbBP5 and ASH2L-deficient complexes, respectively, relative to others
were used for SDS-PAGE. (B) Immunoblot analyses of whole-cell extracts of Sf9 cells infected with baculoviruses in the absence of the indicated subunits
and SET1ACore complexes purified from each cell extract. Note that equal volumes of cell extracts were loaded (lanes 1–6), and the loading of purified
complexes was normalized to FLAG-SET1ACore protein (lanes 7–12). The slightly fast migrating band in anti-WDR5 immunoblot (lane 9) is considered
an insect WDR5 homolog in this and other figures. The upper bands observed in anti-ASH2L immunoblot are considered a post-translationally modified
form(s) of ASH2L in this and other figures. (C and D) H3 (C) and H2Bub chromatin (D) substrates were subjected to in vitro HMT assays with the
indicated subunit-lacking SET1ACore (left) or SET1BCore (right) complexes. Note that because of large differences in intrinsic H3K4 methyltransferase
activities (Figure 1), different concentrations of SET1ACore (15 nM) and SET1BCore complexes (1.5 nM) were used for assays.
ported by the much lower expression of scaffold SET1ACore
and SET1BCore proteins as well as some subunits in Sf9
cells infected with baculoviruses lacking WDR5, RbBP5 or
ASH2L (Figure 2B, lanes 3–5, Supplementary Figure S3B).
Immunoblots of purified complexes, analyzed densito-
metrically and normalized to FLAG-SET1ACore protein
level, led us to draw a number of conclusions regarding
SET1ACoreC integrity that are also generalizable to all other
KMT2Core complexes (Figures 3B and 4B, Supplementary
Figure S3). First, omission of RbBP5 resulted in the con-
comitant disappearance of ASH2L (and DPY30, see below)
(Figure 2B, lane 10), indicating RbBP5-dependent associa-
tion of ASH2L with KMT2 complexes and a pivotal role
of RbBP5 for stable complex formation (see below). This
is consistent with a previous similar reconstitution analysis
of the core MLL1 complex (30) and is further supported
by recent structural studies that revealed interaction net-
works of RbBP5, ASH2L and the SET domain of MLL1 or
MLL3 (29,31,32). Second, exclusion of ASH2L caused the
simultaneous disappearance of DPY30, whereas ASH2L
was retained in the complex in the absence of DPY30 (Fig-
ure 2B, lanes 11 and 12). These results differ from the case
of the yeast Set1 complex, in which Bre2 and Swd1 are
jointly required for their concurrent residence within the
complex (18,33), and thus suggest differential subunit inter-
action networks between yeast and human H3K4 methyl-
transferase complexes.
In vitro HMT assays performed on individual subunit-
lacking complexes using free H3 as the substrate re-
vealed several features in common for both SET1ACore and
SET1BCore complexes. First, CFP1- or DPY30-deficient
complexes exhibited H3K4 methylation activities compara-
ble to that of the intact complex (Figure 2C, lanes 2 and
6 versus lane 1, lanes 8 and 12 versus 7). Second, omis-
sion of RbBP5 and ASH2L resulted in significantly de-
creased H3K4me1 activity and no H3Kme2/3 activities
(Figure 2C, lanes 4, 5, 10 and 11), indicating the criti-
cal roles of these subunits for the intrinsic H3K4 methyl-
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Figure 3. Subunit requirements for H3K4 methylation activities of human MLL1Core and MLL2Core complexes. (A) SDS-PAGE/Coomassie blue staining
of purified MLL1Core complexes lacking the indicated subunits. (B) Whole-cell extracts and purified MLL1Core complexes prepared from Sf9 cells infected
with baculoviruses in the absence of the indicated subunits were subjected to immunoblot analyses as in Figure 2B. (C and D) H3 (C) and H2Bub chromatin
(D) substrates were subjected to in vitro HMT assays with subunit-lacking MLL1Core (left) or MLL2Core (right) complexes (15 nM).
transferase activities of SET1A/BCoreCs; the importance
of these subunits for H3K4 methylation activities also ex-
tended to all other KMT2CoreCs (Figures 3C and 4C). In-
terestingly, and in contrast to the shared contributions of
CFP1, DPY30, RbBP5 and ASH2L subunits to the ac-
tivities of SET1ACoreC and SET1BCoreC, described above,
a WDR5 deficiency had different effects on SET1ACoreC
and SET1BCoreC. Specifically, WDR5-lacking SET1ACoreC
generated markedly decreased levels of H3K4me1 and
failed to generate H3K4me2/3 (Figure 2C, lane 3), whereas
WDR5-deficient SET1BCoreC exhibited only slightly de-
creased H3K4 methylation activity relative to the intact
complex (Figure 2C, lane 9 versus lane 7). These findings
suggest differential contributions of WDR5 to the catalytic
activities of SET1A and SET1B complexes.
We next tested the contributions of each subunit to
H3K4 methylation activities towards an H2Bub-containing
chromatin template. Consistent with previous biochem-
ical analyses of the purified human SET1A complex
(19,34), both intact SET1ACoreC and SET1BCoreC were
able to generate all H3K4 methylation states (Figure
2D, lanes 1 and 7). Although several complexes were
shown to have intrinsic H3K4 methyltransferase activity
towards H3, all SET1ACoreCs lacking any individual sub-
unit completely lacked H3K4 methylation activity (Fig-
ure 2D, lanes 2–6). Unlike the case for SET1ACoreC, all
SET1BCoreCs lacking any of WRAD subunits generated
moderately and markedly weakened levels of H3K4me1 and
H3K4me2/3, respectively (Figure 2D, lanes 9–12). How-
ever, not all subunit effects differed between SET1ACoreC
and SET1BCoreC. As was the case for SET1ACoreC, CFP1-
depleted SET1BCoreC showed a complete loss of H3K4
methylation activity (Figure 2D, lane 8), indicating the
chromatin substrate-specific critical role of the CFP1 sub-
unit, as has also been demonstrated for Spp1 (a yeast CFP1
homolog) in the yeast Set1 complex (18). In relation to
this, we found that omission of WDR5 during complex re-
constitution significantly decreased the level of CFP1 in
SET1ACoreC (Figure 2B, lane 9), but not in SET1BCoreC
(Supplementary Figure S3B) Therefore, based on the es-
sential role of CFP1 for the nucleosomal H3K4 methyla-
tion activities of SET1ACoreC and SET1BCoreC, the loss
of H3K4 methylation activity observed in WDR5-deficient
SET1ACoreC could be explained, at least in part, by the
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Figure 4. Subunit requirements for H3K4 methylation activities of human MLL3Core and MLL4Core complexes. (A) SDS-PAGE/Coomassie blue staining
of purified MLL3Core complexes lacking the indicated subunits. (B) Whole-cell extracts and purified MLL3Core complexes prepared from Sf9 cells infected
with baculoviruses in the absence of the indicated subunits were subjected to immunoblot analyses as in Figure 2B. (C and D) H3 (C) and H2Bub chromatin
(D) substrates were subjected to in vitro HMT assays with the indicated concentrations of subunit-lacking MLL3Core (left) and MLL4Core (right) complexes.
Note that because of weak H3K4 methylation activity (Figure 1), a much higher concentration of MLL3Core complex (40 nM) than MLL4Core complex
(15 nM) was used for chromatin HMT assays.
disappearance of CFP1 in the complex. Thus, our in vitro
system revealed differential subunit requirements for chro-
matin H3K4 methylation activities between SET1A and
SET1B complexes.
Notably, we observed that, albeit little, an insect WDR5
homolog is present in purified SET1A/BCoreCs reconsti-
tuted in the absence of human WDR5 (Figure 2B, lane
9, Supplementary Figure S3B). These SET1A/BCoreCs
showed significantly diminished H3K4 methylation activ-
ities relative to the intact complexes, indicating that the in-
sect homolog does not fully replace the function of hu-
man WDR5 in the complexes. In relation to this and
in support of our observations that WDR5 is required
for the catalytic activities of SET1A/B complexes, a re-
cent biochemical analysis that employed a partial MLL1
complex reconstituted with bacterially expressed subunits
also demonstrated that omission of WDR5 largely de-
creased the H3K4 methylation activity of the complex
(29).
All WRAD subunits are required for nucleosomal H3K4
methylation activities of human MLL1Core and MLL2Core
complexes
We next tested subunit requirements for the H3K4 methy-
lation activities of purified MLL1CoreC (Figure 3A) and
MLL2CoreC (Supplementary Figure S3C), of which sub-
unit compositions were examined by immunoblot analyses
(Figure 3B, Supplementary Figure S3D). In in vitro HMT
assays with free H3, intact MLL1CoreC and MLL2CoreC
containing all WRAD subunits were able to generate all
H3K4 methylation states. As was the case for SET1BCoreC,
RbBP5 and ASH2L were found to be essential for H3K4
methylation activity, whereas WDR5 and DPY30 were dis-
pensable (Figure 3C). Consistent with previous biochemical
analyses of purified human MLL1 and MLL2 complexes
(35,36), both intact MLL1CoreC and MLL2CoreC were able
to generate all three H3K4 methylation states (Figure 3D,
lanes 1 and 6) with similar activities (Figure 1D) towards
H2Bub-containing chromatin templates. We further found
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that, with the exception of very weak residual H3K4me1 ac-
tivity in the specific absence of WDR5, exclusion of WRAD
subunits led to a complete loss of H3K4 methylation activi-
ties (Figure 3D, lanes 2–5 and 7–10), demonstrating the es-
sential roles of all WRAD subunits for nucleosomal H3K4
methylation by MLL1 and MLL2 complexes.
To confirm stable complex formations, all MLL2CoreCs
reconstituted without a single subunit were further analyzed
by size exclusion chromatography (Supplementary Figure
S4). We found that MLL2CoreCs reconstituted in the ab-
sence of WDR5, ASH2L or DPY30 were shown to form
stable complexes. In contrast, RbBP5-deficient complex re-
tained only MLL2Core fragment and WDR5, and was di-
luted out during gel filtration, indicating a critical role of
RbBP5 for stable complex formation. This is consistent
with recent structural studies that revealed extensive con-
tacts of RbBP5 with other subunits, which are important for
stable complex formation (29,31,32). Therefore, lack of the
H3K4 methylation activity of RbBP5-deficient complexes is
considered to be attributed by the absence of multiple cat-
alytic subunits.
Differential subunit requirements of human MLL3Core and
MLL4Core complexes for nucleosomal H3K4 methylation ac-
tivity
We then examined subunit requirements of purified
MLL3CoreC (Figure 4A) and MLL4CoreC (Supplementary
Figure S3E) for H3K4 methylation activity. Unlike the com-
plexes described above, we found that protein expression
level of scaffold MLL3CoreC was not decreased in the ab-
sence of WDR5 (Figure 4B, lane 2 versus lane 1), which
allowed us to obtain a purified WDR5-deficient complex
at a concentration comparable to that of the intact com-
plex. This also suggests a distinct contribution of WDR5
to the assembly of the MLL3 complex, possibly leading
to different effects of WDR5 on H3K4 methylation activ-
ity compared with that in other complexes (see below). In
vitro HMT assays revealed that the intrinsic methyltrans-
ferase activity of MLL3CoreC on free H3 was restricted
to H3K4me1/2, and required RbBP5 and ASH2L, but
not WDR5 and DPY30 (Figure 4C, lanes 1–5). Inter-
estingly, we found that WDR5-deficient MLL3CoreC ex-
hibited slightly increased H3K4me1/2 activities relative
to the intact complex (Figure 4C, lane 2 versus lane 1).
This is consistent with a previous similar HMT assay
that employed a partial MLL3 complex (equivalent to our
MLL3WinC, see below) and H3 peptides as the substrates
(37). In accordance with the role of MLL3 as a major
H3K4 mono-methyltransferase around enhancer regions
(38), chromatin methylation activity of MLL3CoreC was re-
stricted to H3K4me1 (Figure 4D, lane 1). This activity was
almost completely lost in the absence of RbBP5, ASH2L
and DPY30 but, importantly was not diminished by omis-
sion of WDR5 (Figure 4D, lanes 2–5). In a related observa-
tion, a recent study showed that omission of WDR5 from
a partial MLL3 complex (equivalent to our MLL3WinC)
reconstituted with bacterially expressed proteins rather in-
creased H3K4me1 activity of the complex (29). These find-
ings reflect the clearly different pattern of MLL3CoreC ac-
tivity compared with that of MLL1/2CoreCs (Figure 3D)
and further suggest differences in structural organization
between MLL3 and other KMT2 complexes (29).
H3K4 methylation activity of purified MLL4CoreC to-
wards free H3 was dependent on RbBP5 and ASH2L (Fig-
ure 4C, lanes 6–10). As was the case for MLL1/2CoreCs,
MLL4CoreC also required all WRAD subunits for chro-
matin methylation activities but retained weak H3K4me1
activity in the absence of WDR5 (Figure 4D, lanes 6–10).
In addition, similar to the cases for SET1A/BCoreCs and
MLL2CoreC, MLL3/4CoreCs further purified by gel filtra-
tion exhibited indistinguishable H3K4 methylation activi-
ties to those of the affinity-purified complexes (Supplemen-
tary Figure S5).
The n-SET domain is essential for nucleosomal H3K4 methy-
lation activities of SET1ACore and SET1BCore complexes
So far, we have examined H3K4 methylation activities of
KMT2Core complexes that contain partial KMT2 fragments
harboring entire n-SET or pre-SET domains at their N-
terminus (Figure 1A). However, all previous biochemical
and structural analyses have employed complexes contain-
ing partial KMT2 fragments encompassing a region be-
ginning near the WDR5-interaction (Win) motif residing
within their n-SET or pre-SET domains because these com-
plexes are minimally sufficient to exert H3K4 methylation
activity (29,32,37,39). In a related observation, the SET do-
main of the yeast Set1 complex alone was shown to be suf-
ficient to form a stable complex with all WRAD homologs
(18,21,39); however, we failed to purify stable complex us-
ing the SET domain from any human KMT2 protein and
WRAD subunits (data not shown). Collectively, these re-
sults indicate that, in addition to the SET domain, the Win
motif located in the N-terminus is also required for stable
complex formation, as previously reported (40,41).
To test H3K4 methylation activities of complexes con-
taining KMT2 protein fragments that are minimally suf-
ficient to form complexes with WRAD subunits, we re-
constituted partial human KMT2 Win complexes (here-
after, KMT2WinCs) and affinity purified them from Sf9 in-
sect cells infected with baculoviruses expressing FLAG-
KMT2Win protein fragments (encompassing the Win mo-
tif, SET and post-SET domains) (37) and untagged WRAD
and CFP1 (Figure 5A). From the standpoint of complex
integrity, we found that all WRAD subunits were stably in-
tegrated into all purified complexes, but CFP1 was absent
(Figure 5B). The absence of SET1A/B complex-specific
CFP1 (Figure 1B) in SET1A/BWinCs suggests that the miss-
ing N-terminal region of the n-SET domain is required
for retention of CFP1 in SET1A and SET1B complexes.
All KMT2WinCs exhibited H3K4 methylation activities to-
wards free H3, exhibiting relative catalytic strengths and
product methylation states similar to those of KMT2CoreCs
(compare Figure 5C and 1C). These findings confirm that
KMT2Win protein fragments are sufficient to confer intrin-
sic catalytic activities to the complexes. Strikingly different
results were obtained in in vitro HMT assays using chro-
matin templates. All MLL1/2/3/4WinCs exhibited H3K4
methylation activities (Figure 5D, lanes 5–12), with patterns
of H2Bub-stimulatory methylation states generally similar
to those of MLL1/2/3/4CoreCs. Importantly, however, both
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Figure 5. H3K4 methylation activities of human KMT2Win complexes. (A) A schematic diagram of KMT2Win fragments used for the reconstitution
of complexes and subunit associations deduced from (B). The SET and post-SET (hatched box) domain and Win (red box) motif within each KMT2
protein are depicted. Numbers indicate amino acid residues of each protein. Note that all proteins contain truncated n-SET or pre-SET domains. (B)
SDS-PAGE/Coomassie blue staining (left) and immunoblot analyses (right) of purified KMT2Win complexes reconstituted with baculoviruses expressing
FLAG-tagged KMT2Win protein (A), WDR5, RbBP5, ASH2L, DPY30 and CFP1. KMT2Win proteins are marked by asterisks. (C) Differential H3K4
methylation activities of KMT2Win complexes towards H3 substrate. H3 was subjected to in vitro HMT assays with the indicated KMT2Win complexes (7.5
nM). (D) Differential H3K4 methylation activities of KMT2Win complexes towards chromatin substrates. Unmodified or H2Bub chromatin substrates were
subjected to in vitro HMT assays with the indicated KMT2Win complexes (5 nM). (E) Comparison of H3K4 methylation activities of SET1A/BWin and
SET1A/BCore complexes. Unmodified and H2Bub chromatin substrates were subjected to in vitro HMT assays with SET1AWin and SET1ACore complexes
(left) and SET1BWin and SET1BCore complexes (right), present at a final concentration of 10 nM.
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SET1AWinC and SET1BWinC showed a complete loss of
H3K4me2/3 activities, even in the presence of H2Bub (Fig-
ure 5D, lanes 1–4), despite the fact that SET1BCoreC showed
the strongest activity among all KMT2CoreCs. A direct com-
parison of H3K4 methylation activities further confirmed
that SET1A/BWinCs, in contrast to SET1A/BCoreCs, do not
possess H2Bub-dependent nucleosomal H3K4 methylation
activity (Figure 5E). These results indicate that n-SET do-
mains, likely in conjunction with associating CFP1 subunits
(see below), play a critical role in regulating the catalytic ac-
tivities of SET1A and SET1B complexes.
The PHD2 domain within CFP1 is essential for H2B
ubiquitylation-dependent H3K4me2 and H3K4me3 activities
of SET1ACore and SET1BCore complexes
The disappearance of CFP1 in SET1A/BWinCs caused by
n-SET domain truncation raises the possibility that the ob-
served loss of H3K4 methylation activities of these com-
plexes is attributable to the lack of CFP1. In this same
vein, we showed above that CFP1-deficient SET1A/BCoreCs
are completely inactive with respect to nucleosomal H3K4
methylation (Figure 2D), establishing a critical role of CFP1
in catalytic activity that is specific to SET1A/B complexes.
CFP1 contains two evolutionarily conserved PHDs
(plant homeodomains), a SID (Set1-interacting domain),
and a CXXC domain with demonstrated individual func-
tions in binding to methylated histones (42), SET1A/B
proteins (43), and unmethylated CpG islands around pro-
moter regions (44,45), respectively. To determine the do-
main within CFP1 that is involved in the H3K4 methy-
lation activity of the SET1A complex, we reconstituted
SET1ACore protein-based complexes and affinity purified
them from Sf9 cells infected with baculoviruses express-
ing FLAG-SET1ACore protein, untagged WRAD, and His-
tagged wild-type (WT) or mutant CFP1 (Figure 6A). (Note
that the complex containing SID-CFP1 was not included
because this protein was not expressed in soluble form in
Sf9 cells). All subunits were found to be stably integrated
into the complex (Figure 6B). In tests designed to deter-
mine the contribution of each domain within CFP1 to in-
trinsic H3K4 methyltransferase activity towards free H3, all
complexes exhibited comparable levels of all H3K4 methy-
lation states (Figure 6C). In in vitro HMT assays using
chromatin templates, complexes containing PHD1-CFP1
or CXXC-CFP1 generated all three H3K4 methylation
states at levels comparable to those observed with the com-
plete SET1ACoreC in the presence of H2Bub (Figure 6D,
lanes 8 and 9 versus lane 6). Importantly, we further found
that the complex reconstituted with PHD2-CFP1 was ca-
pable of producing H3K4me1, but completely failed to gen-
erate H3K4me2/3 (Figure 6D, lane 10). Notably, because
the PHD2 complex showed intrinsic H3K4me1 activity
(Figure 6D, lane 5), these results strongly suggest that the
PHD2 domain plays a critical role in H2Bub-dependent
H3K4me2/3 activities. In addition, the same series of exper-
iments performed with SET1BCoreC (Supplementary Fig-
ure S6) collectively indicate a critical role for CFP1 PHD2
in the H2Bub-dependent H3K4 methylation activities of
SET1A and SET1B complexes. Given that WRAD subunits
alone are insufficient and that CFP1 is additionally required
for SET1A/BCoreCs to exhibit efficient H3K4 methylation
activities, these results suggest that CFP1 works together
with WRAD to establish H3K4 methylation-competent
SET1A/B complexes, as proposed for the yeast Set1 com-
plex (20,21). In addition, the SET1A/BCoreC-specific re-
quirement of CFP1 for catalytic activity strongly suggests
that the H3K4 methylation mechanism is somewhat differ-
ent for SET1A/B and MLL1/2/3/4 complexes (see Discus-
sion).
Comparisons of H3K4 methylation activities of full-length
KMT2-containing complexes
To directly compare intrinsic H3K4 methyltransferase ac-
tivities, we have deployed biochemical analyses using par-
tial KMT2 complexes containing KMT2 protein fragments
and the subunits that are minimally required for catalytic
activity. However, it is still important to analyze biochemi-
cal properties of complete KMT2 complexes to understand
their precise in vivo functions. Although several previous
studies have reported H3K4 methylation activities of in-
dividual KMT2 complexes (34–36,46), there have been no
comprehensive biochemical characterizations and compar-
isons of intact KMT2 complexes prepared using identical
conditions. On a related note, we tried to prepare recombi-
nant complexes containing full-length KMT2 protein and
all subunits of the complex using a baculovirus expression
system, but these approaches have so far proved unsuc-
cessful (data not shown). Instead, we found that we could
successfully reconstitute SET1A, SET1B and MLL2 com-
plexes and affinity purify them from HEK293E cells trans-
fected with combinations of plasmids expressing FLAG-
tagged KMT2 proteins and subunits that constitute each
complex (7) (Figure 7A and B). (Note that the same ap-
proach was not successful for the MLL1 complex, and we
did not attempt to purify MLL3/4 complexes owing to dif-
ficulties in preparing plasmids expressing full-length MLL3
or MLL4.)
In tests of intrinsic enzymatic activities, all purified com-
plete complexes generated H3K4 methylation to differ-
ent degrees. Similar to the case for KMT2CoreCs (Figure
1C), SET1B and MLL2 complexes exhibited much stronger
H3K4 methylation activities towards free H3 than did the
SET1A complex (Figure 7C). Likewise, we also found that
all complete complexes were able to generate all H3K4
methylation states and, importantly, generated these states
at increased levels in the presence of nucleosomal H2Bub
(Figure 7D). The rank order of the strengths of enzyme ac-
tivities were SET1B > MLL2 > SET1A complexes, which
is the same order as that obtained with KMT2CoreCs (Fig-
ure 1D). These results validate our comparative biochem-
ical analyses using KMT2Core complexes for recapitulating
H3K4 methylation activities of complete KMT2 complexes.
DISCUSSION
The presence of multiple KMT2 family complexes and
many other cellular factors that directly and indirectly af-
fect H3K4 methylation makes it difficult to address how
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Figure 6. Requirement of CFP1 domains for H3K4 methylation activities of the human SET1ACore complex. (A) A schematic diagram of SET1ACore
protein-based complexes containing wild-type (WT) or mutant CFP1. PHD1, CXXC, SID, and PHD2 domains are depicted. Physical interactions between
subunits were deduced from previous structural studies of human MLL1 and MLL3 complexes (29,31,32). Abbreviations: W, WDR5; R, RbBP5; A,
ASH2L; D, DPY30. (B) SDS-PAGE/Coomassie blue staining (left) and immunoblot analyses (right) of purified SET1ACore protein-based complexes
reconstituted with baculoviruses expressing FLAG-tagged SET1ACore protein, WDR5, RbBP5, ASH2L, DPY30 and His-tagged WT or mutant CFP1.
His-CFP1 polypeptides are marked by asterisks. (C and D) Requirement of the PHD2 domain of CFP1 for H2Bub-dependent H3K4 methylation activities
of the SET1ACore complex. H3 (C) and unmodified or H2Bub chromatin substrates (D) were subjected to in vitro HMT assays with the indicated SET1ACore
protein-based complexes (15 nM).
each KMT2 complex contributes individually to the levels
and states of H3K4 methylation in cells. To directly assess
the catalytic properties of all six human KMT2 complexes,
we used biochemically defined in vitro HMT assays em-
ploying purified KMT2 complexes and recombinant chro-
matin substrates. Our studies provide a number of valu-
able insights regarding the nucleosomal H3K4 methylation
activities of human KMT2 complexes: (i) H2Bub stimu-
lates H3K4 methylation activities of KMT2 complexes; (ii)
H2Bub is strictly required for H3K4me2/3 activities of the
SET1A complex, but is dispensable for SET1B complex
activities; (iii) the SET1B complex exhibits the strongest
H3K4 methylation activity among KMT2 complexes; (iv)
the CFP1 PHD2 domain plays a critical role in the cat-
alytic activities of SET1A and SET1B complexes; (v) MLL1
and MLL2 complexes can generate comparable levels of all
H3K4 methylation states; (vi) the H3K4 methylation activ-
ity of MLL3 is restricted to H3K4me1, whereas MLL4 can
produce both H3K4me1 and H3K4me2; (vii) in contrast to
the case for other complexes, WDR5 is dispensable for the
H3K4me1 activity of the MLL3 complex. Taken together,
these results provide fundamental insights into nucleosomal
H3K4 methylation activities of human KMT2 complexes.
Previous biochemical analyses using purified KMT2
complexes prepared by bacterial (37) or baculovirus (39)
expression systems also reported their differential H3K4
methylation activities towards H3 peptide (37) or non-
ubiquitylated recombinant nucleosome (39). It is impor-
tant to note that these analyses employed complexes con-
taining partial KMT2 fragments encompassing a region
beginning near the Win motif, which are equivalent to
KMT2WinCs in our study (Figure 5). In contrast, we used
KMT2Core fragments that contain entire n-SET or pre-
SET domains at their N-terminus for complex reconstitu-
tions (i.e. KMT2CoreCs), which allowed incorporation of
CFP1 specifically into SET1A and SET1B complexes (Fig-
ure 1). This allowed us to uniquely demonstrate a criti-
cal role of the CFP1 subunit in the H3K4 methylation ac-
tivities of SET1A and SET1B complexes towards physio-
logically relevant H2Bub-containing chromatin substrates
(Figures 2 and 6), which was not addressed by previous
studies.
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Figure 7. H3K4 methylation activities of human SET1A, SET1B, and MLL2 complexes. (A and B) SDS-PAGE/Coomassie blue staining (A) and im-
munoblot analyses (B) of SET1A, SET1B, and MLL2 complexes purified from HEK293E cells transfected with combinations of plasmids expressing
subunits that constitute each complex. MLL2N and MLL2C, N-terminal and C-terminal parts of MLL2, respectively, resulting from Taspase 1 cleavage
(54). (C and D) Differential H3K4 methylation activities of SET1A, SET1B, and MLL2 complexes. H3 (C) and unmodified or H2Bub chromatin substrates
(D) were subjected to in vitro HMT assays with the indicated complexes (5 nM).
H3K4 methylation activities of human KMT2 complexes to-
wards chromatin templates
Our ability to reconstitute KMT2 complexes lacking spe-
cific subunits allowed us to directly assess the contribu-
tion of individual subunits to H3K4 methylation activities
towards free H3 and chromatin templates. For all KMT2
complexes, we found that all WRAD subunits are required
for full H3K4 methylation activities towards chromatin (ex-
cept WDR5 for MLL3 complex), but only RbBP5 and
ASH2L are essential for methylation of free H3. These dif-
ferent subunit requirements reflect the fact that extensive
subunit interactions with DNA, as well as new binding sur-
face created by the nucleosome structure, are critical for nu-
cleosomal H3K4 methylation (20,22,29,31,32). They also
highlight the merits of our biochemical analyses using phys-
iologically relevant chromatin substrates rather than free hi-
stone substrates for proper characterization of chromatin-
modifying enzymes.
The large differences in enzymatic activities observed for
SET1ACoreC and SET1BCoreC (Figure 1E) indicate that
KMT2 protein itself determines the catalytic power of the
complex. SET1BCoreC exhibited reduced, but still signifi-
cant, H3K4 methylation activities in the absence of H2Bub,
even at much lower concentrations than SET1ACoreC. This
suggests that the Set1 protein underwent divergent evolu-
tion to produce one weak descendant (SET1A) and one
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strong descendant (SET1B). Structural studies detailing
how SET1A and SET1B proteins differentially contribute
to catalytic power are warranted.
In support of our finding that SET1A complex has a
weak catalytic activity, it was reported that the removal of
the SET1A SET domain in mouse V6.5 embryonic stem
cells did not diminish global H3K4 methylation level; in-
stead, only a subset of genes shows decreased H3K4me3
levels (47). Consistent with this, shRNA-mediated deple-
tion of SET1A was shown to have no effect on global H3K4
methylation levels in cancer cell lines (48,49). In addition, in
a test for the relative contribution of SET1A and SET1B to
cellular H3K4 methylation, we further found that ectopic
expression of SET1B resulted in more significant increases
in global H3K4me2/3 levels than that of SET1A (Supple-
mentary Figure S7). In contrast to above results, another
study has reported that inducible knockout of SET1A led
to a significant reduction in global H3K4 methylation lev-
els in mouse R1 embryonic stem cells and embryos, whereas
that of SET1B had no effect (50), suggesting a principal
role of SET1A in the maintenance of global H3K4 methy-
lation levels in their study. However, in relation to the lat-
ter observation, it is worth to note that the HeLa cell nu-
cleus contains about 130-fold more SET1A than SET1B
as demonstrated by quantitative mass spectrometric anal-
ysis (51). Therefore, SET1A could have a more significant
effect on H3K4 methylation levels in some cells that con-
tain SET1A as a dominant population although its intrinsic
catalytic activity is much weaker than SET1B. Collectively,
these suggest that, in addition to intrinsic enzyme activities,
several features of KMT2 proteins, including their relative
amounts in cells and subcellular localization that could vary
according to cell types and developmental stages (51,52) de-
termine cellular H3K4 methylation levels.
A notable difference among KMT2Core proteins is that
SET1 and MLL homologs have n-SET and pre-SET do-
mains, respectively. To test whether these domains affected
the catalytic properties of other groups of homologs, we
performed domain-swapping experiments (Supplementary
Figure S8). We found that fusion of the SET1B n-SET do-
main to the MLL3 or MLL4 SET and post-SET domains
resulted in inclusion of CFP1 in purified complexes that ex-
hibited significantly enhanced H3K4 methylation activities.
Importantly, however, the methylation states remained un-
changed. These observations suggest that the amino acid
sequence within each SET domain itself determines the
methylation product states of the complex. Support for
this is provided by the previous demonstration that unique
amino acid sequences in the SET domain of MLL3 specify
its H3Kme1-restricted activity (39,53).
H2B ubiquitylation stimulates H3K4 methylation activities
of human KMT2 complexes
Because of similarities in domain architecture and subunit
composition between SET1A/B complexes and the yeast
Set1 complex (7), we initially expected that only SET1A and
SET1B complexes would exhibit H2Bub-dependent H3K4
methylation activities. Surprisingly, however, we found that
all KMT2 complexes (except MLL3, see above) exhibited
H2Bub-stimulated H3K4 methylation activities, suggesting
that a component(s) common to all complexes might be re-
sponsible for this trans-tail stimulatory effect. In support
of this suggestion, a recent study demonstrated that the
WD40 domain of RbBP5 directly binds to H2Bub, leading
to more extensive and stabilized binding of MLL1 or MLL3
to nucleosomes and thus enhanced catalytic activities of the
complexes (29). Because RbBP5 is present in all complexes,
it might contribute to H2Bub-mediated enhanced H3K4
methylation activities through the same mechanism.
In addition, a very recent structural study on the yeast
Set1 complex proposed another mechanism to explain how
H2Bub activates H3K4 methylation (20,22). According to
this model, the arginine-rich RXXXRR motif that we pre-
viously demonstrated critical for the H2Bub-dependent
H3K4 methylation activity of the Set1 complex (18) makes
extensive contacts with H2Bub as well as the acidic patch of
histones H2A and H2B; thus, increased nucleosome inter-
action potentiates H3K4 methylation activity. Because the
RXXXRR motif is conserved only in human SET1A/B but
not in MLL1/2/3/4, this mechanism could be specific to
SET1A and SET1B complexes. In this context, the greater
enhancement of H3K4 methylation activities by H2Bub ob-
served in SET1A/BCoreCs compared with MLL1/2/4CoreCs
(Supplementary Figure S1) could be explained by coopera-
tive contributions of the RbBP5 subunit and the RXXXRR
motif in SET1A/B. In relation to this, we also found that
mutations in the RXXXRR motif resulted in complete
loss of the H3K4 methylation activities of SET1A/BCoreCs
(Supplementary Figure S9), suggesting an evolutionarily
conserved role of the RXXXRR motif in the regulation of
H3K4 methylation activities of SET1A and SET1B com-
plexes.
In a related observation, we found that SET1AWinC exert
no H3K4me2/3 activities, even in the presence of H2Bub
(Figure 5D), despite the fact that these complexes con-
tain both RbBP5 and the RXXXRR motif. Instead, we
found that inclusion of the n-SET domain and CFP1 (i.e.
SET1ACoreC) converts the complexes into an H3K4me2/3-
active form in the presence of H2Bub (Figure 5E). In con-
trast to other domain-defective complexes, the CFP1 PHD2
domain-deficient SET1ACoreC showed no H3K4me2/3 ac-
tivities in the presence of H2Bub, but did exhibit intrin-
sic H3K4me1 activity (Figure 6D). These results strongly
suggest that CFP1 acts through its PHD2 to participate in
H2Bub-induced H3K4me2/3 activities of SET1A complex.
Additional structural analyses of CFP1-containing com-
plexes will be needed to detail the contribution of CFP1 to
this process.
In the current study, using a biochemically defined sys-
tem reconstituted with recombinant human KMT2 com-
plexes and recombinant chromatin substrates, we found
that each KMT2 complex generates distinct H3K4 methy-
lation states and different levels of methylation, suggest-
ing mechanistic differences in H3K4 methylation processes
among KMT2 complexes. This detailed catalytic character-
ization will be invaluable for guiding and interpreting high-
resolution structural studies of KMT2 complexes that have
recently begun to emerge, to identify roles of KMT2 com-
plexes in transcriptional regulation, and for future epige-
netic drug development efforts related to H3K4 methyla-
tion.
Nucleic Acids Research, 2020, Vol. 48, No. 10 5455
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
We thank Dr. Robert G. Roeder for anti-CFP1 and anti-
WDR82 antibodies; Dr. C. David Allis for anti-WDR5 an-
tibody; and Dr. Daeyoup Lee for valuable discussion.
FUNDING
Samsung Science and Technology Foundation [SSTF-
BA1702-13 to J.K.]; National Institutes of Health [R37
GM086868, P01 CA196539 to T.W.M., P01DK068055 to
J.H.L., 1ZIADK075003 to K.G.]. Funding for open ac-
cess charge: Samsung Science and Technology Foundation
[SSTF-BA1702-13].
Conflict of interest statement. None declared.
REFERENCES
1. Hyun,K., Jeon,J., Park,K. and Kim,J. (2017) Writing, erasing and
reading histone lysine methylations. Exp. Mol. Med., 49, e324.
2. Li,B., Carey,M. and Workman,J.L. (2007) The role of chromatin
during transcription. Cell, 128, 707–719.
3. Rivera,C., Gurard-Levin,Z.A., Almouzni,G. and Loyola,A. (2014)
Histone lysine methylation and chromatin replication. Biochim.
Biophys. Acta, 1839, 1433–1439.
4. Chi,P., Allis,C.D. and Wang,G.G. (2010) Covalent histone
modifications––miswritten, misinterpreted and mis-erased in human
cancers. Nat. Rev. Cancer, 10, 457–469.
5. Collins,B.E., Greer,C.B., Coleman,B.C. and Sweatt,J.D. (2019)
Histone H3 lysine K4 methylation and its role in learning and
memory. Epigenet. Chromatin, 12, 7.
6. Rao,R.C. and Dou,Y. (2015) Hijacked in cancer: the KMT2 (MLL)
family of methyltransferases. Nat. Rev. Cancer, 15, 334–346.
7. Shilatifard,A. (2012) The COMPASS family of histone H3K4
methylases: mechanisms of regulation in development and disease
pathogenesis. Annu. Rev. Biochem., 81, 65–95.
8. Crump,N.T. and Milne,T.A. (2019) Why are so many MLL lysine
methyltransferases required for normal mammalian development?
Cell. Mol. Life Sci., 76, 2885–2898.
9. Yang,W. and Ernst,P. (2017) Distinct functions of histone H3, lysine 4
methyltransferases in normal and malignant hematopoiesis. Curr.
Opin. Hematol., 24, 322–328.
10. Yang,W. and Ernst,P. (2017) SET/MLL family proteins in
hematopoiesis and leukemia. Int. J. Hematol., 105, 7–16.
11. Harikumar,A. and Meshorer,E. (2015) Chromatin remodeling and
bivalent histone modifications in embryonic stem cells. EMBO Rep.,
16, 1609–1619.
12. Jiang,Y., Dominguez,P.M. and Melnick,A.M. (2016) The many layers
of epigenetic dysfunction in B-cell lymphomas. Curr. Opin. Hematol.,
23, 377–384.
13. Froimchuk,E., Jang,Y. and Ge,K. (2017) Histone H3 lysine 4
methyltransferase KMT2D. Gene, 627, 337–342.
14. Wang,C., Lee,J.E., Lai,B., Macfarlan,T.S., Xu,S., Zhuang,L., Liu,C.,
Peng,W. and Ge,K. (2016) Enhancer priming by H3K4
methyltransferase MLL4 controls cell fate transition. Proc. Natl.
Acad. Sci. U.S.A., 113, 11871–11876.
15. Lee,J.E., Wang,C., Xu,S., Cho,Y.W., Wang,L., Feng,X., Baldridge,A.,
Sartorelli,V., Zhuang,L., Peng,W. and Ge,K. (2013) H3K4 mono- and
di-methyltransferase MLL4 is required for enhancer activation during
cell differentiation. eLife, 2, e01503.
16. Dover,J., Schneider,J., Tawiah-Boateng,M.A., Wood,A., Dean,K.,
Johnston,M. and Shilatifard,A. (2002) Methylation of histone H3 by
COMPASS requires ubiquitination of histone H2B by Rad6. J. Biol.
Chem., 277, 28368–28371.
17. Sun,Z.W. and Allis,C.D. (2002) Ubiquitination of histone H2B
regulates H3 methylation and gene silencing in yeast. Nature, 418,
104–108.
18. Kim,J., Kim,J.A., McGinty,R.K., Nguyen,U.T., Muir,T.W.,
Allis,C.D. and Roeder,R.G. (2013) The n-SET domain of Set1
regulates H2B ubiquitylation-dependent H3K4 methylation. Mol.
Cell, 49, 1121–1133.
19. Kim,J., Guermah,M., McGinty,R.K., Lee,J.S., Tang,Z., Milne,T.A.,
Shilatifard,A., Muir,T.W. and Roeder,R.G. (2009) RAD6-mediated
transcription-coupled H2B ubiquitylation directly stimulates H3K4
methylation in human cells. Cell, 137, 459–471.
20. Hsu,P.L., Shi,H., Leonen,C., Kang,J., Chatterjee,C. and Zheng,N.
(2019) Structural basis of H2B ubiquitination-dependent H3K4
methylation by COMPASS. Mol. Cell, 76, 712–723.
21. Jeon,J., McGinty,R.K., Muir,T.W., Kim,J.A. and Kim,J. (2018)
Crosstalk among Set1 complex subunits involved in H2B
ubiquitylation-dependent H3K4 methylation. Nucleic Acids Res., 46,
11129–11143.
22. Worden,E.J., Zhang,X. and Wolberger,C. (2020) Structural basis for
COMPASS recognition of an H2B-ubiquitinated nucleosome. eLife,
9, e53199.
23. Kim,J. and Roeder,R.G. (2011) Nucleosomal H2B ubiquitylation
with purified factors. Methods, 54, 331–338.
24. Dukkipati,A., Park,H.H., Waghray,D., Fischer,S. and Garcia,K.C.
(2008) BacMam system for high-level expression of recombinant
soluble and membrane glycoproteins for structural studies. Protein
Expr. Purif., 62, 160–170.
25. McGinty,R.K., Kohn,M., Chatterjee,C., Chiang,K.P., Pratt,M.R.
and Muir,T.W. (2009) Structure-activity analysis of semisynthetic
nucleosomes: mechanistic insights into the stimulation of Dot1L by
ubiquitylated histone H2B. ACS Chem. Biol., 4, 958–968.
26. An,W., Kim,J. and Roeder,R.G. (2004) Ordered cooperative
functions of PRMT1, p300, and CARM1 in transcriptional
activation by p53. Cell, 117, 735–748.
27. Lee,J.H. and Skalnik,D.G. (2005) CpG-binding protein (CXXC
finger protein 1) is a component of the mammalian Set1 histone
H3-Lys4 methyltransferase complex, the analogue of the yeast
Set1/COMPASS complex. J. Biol. Chem., 280, 41725–41731.
28. Lee,J.H., Tate,C.M., You,J.S. and Skalnik,D.G. (2007) Identification
and characterization of the human Set1B histone H3-Lys4
methyltransferase complex. J. Biol. Chem., 282, 13419–13428.
29. Xue,H., Yao,T., Cao,M., Zhu,G., Li,Y., Yuan,G., Chen,Y., Lei,M.
and Huang,J. (2019) Structural basis of nucleosome recognition and
modification by MLL methyltransferases. Nature, 573, 445–449.
30. Dou,Y., Milne,T.A., Ruthenburg,A.J., Lee,S., Lee,J.W., Verdine,G.L.,
Allis,C.D. and Roeder,R.G. (2006) Regulation of MLL1 H3K4
methyltransferase activity by its core components. Nat. Struct. Mol.
Biol., 13, 713–719.
31. Park,S.H., Ayoub,A., Lee,Y.T., Xu,J., Kim,H., Zhang,W., Zhang,B.,
Sha,L., An,S., Zhang,Y. et al. (2019) Cryo-EM structure of the human
MLL1 core complex to the nucleosome. Nat. Commun., 10, 5540.
32. Li,Y., Han,J., Zhang,Y., Cao,F., Liu,Z., Li,S., Wu,J., Hu,C., Wang,Y.,
Shuai,J. et al. (2016) Structural basis for activity regulation of MLL
family methyltransferases. Nature, 530, 447–452.
33. South,P.F., Fingerman,I.M., Mersman,D.P., Du,H.N. and
Briggs,S.D. (2010) A conserved interaction between the SDI domain
of Bre2 and the Dpy-30 domain of Sdc1 is required for histone
methylation and gene expression. J. Biol. Chem., 285, 595–607.
34. Tang,Z., Chen,W.Y., Shimada,M., Nguyen,U.T., Kim,J., Sun,X.J.,
Sengoku,T., McGinty,R.K., Fernandez,J.P., Muir,T.W. et al. (2013)
SET1 and p300 act synergistically, through coupled histone
modifications, in transcriptional activation by p53. Cell, 154, 297–310.
35. Dou,Y., Milne,T.A., Tackett,A.J., Smith,E.R., Fukuda,A.,
Wysocka,J., Allis,C.D., Chait,B.T., Hess,J.L. and Roeder,R.G. (2005)
Physical association and coordinate function of the H3 K4
methyltransferase MLL1 and the H4 K16 acetyltransferase MOF.
Cell, 121, 873–885.
36. Jiang,H., Lu,X., Shimada,M., Dou,Y., Tang,Z. and Roeder,R.G.
(2013) Regulation of transcription by the MLL2 complex and MLL
complex-associated AKAP95. Nat. Struct. Mol. Biol., 20, 1156–1163.
37. Shinsky,S.A., Monteith,K.E., Viggiano,S. and Cosgrove,M.S. (2015)
Biochemical reconstitution and phylogenetic comparison of human
SET1 family core complexes involved in histone methylation. J. Biol.
Chem., 290, 6361–6375.
38. Hu,D., Gao,X., Morgan,M.A., Herz,H.M., Smith,E.R. and
Shilatifard,A. (2013) The MLL3/MLL4 branches of the COMPASS
5456 Nucleic Acids Research, 2020, Vol. 48, No. 10
family function as major histone H3K4 monomethylases at
enhancers. Mol. Cell. Biol., 33, 4745–4754.
39. Hsu,P.L., Li,H., Lau,H.T., Leonen,C., Dhall,A., Ong,S.E.,
Chatterjee,C. and Zheng,N. (2018) Crystal structure of the
COMPASS H3K4 methyltransferase catalytic module. Cell, 174,
1106–1116.
40. Patel,A., Vought,V.E., Dharmarajan,V. and Cosgrove,M.S. (2008) A
conserved arginine-containing motif crucial for the assembly and
enzymatic activity of the mixed lineage leukemia protein-1 core
complex. J. Biol. Chem., 283, 32162–32175.
41. Song,J.J. and Kingston,R.E. (2008) WDR5 interacts with mixed
lineage leukemia (MLL) protein via the histone H3-binding pocket. J.
Biol. Chem., 283, 35258–35264.
42. Eberl,H.C., Spruijt,C.G., Kelstrup,C.D., Vermeulen,M. and
Mann,M. (2013) A map of general and specialized chromatin readers
in mouse tissues generated by label-free interaction proteomics. Mol.
Cell, 49, 368–378.
43. Butler,J.S., Lee,J.H. and Skalnik,D.G. (2008) CFP1 interacts with
DNMT1 independently of association with the Setd1 Histone H3K4
methyltransferase complexes. DNA Cell Biol., 27, 533–543.
44. Brown,D.A., Di Cerbo,V., Feldmann,A., Ahn,J., Ito,S.,
Blackledge,N.P., Nakayama,M., McClellan,M., Dimitrova,E.,
Turberfield,A.H. et al. (2017) The SET1 complex selects actively
transcribed target genes via multivalent interaction with CpG island
chromatin. Cell Rep., 20, 2313–2327.
45. Voo,K.S., Carlone,D.L., Jacobsen,B.M., Flodin,A. and Skalnik,D.G.
(2000) Cloning of a mammalian transcriptional activator that binds
unmethylated CpG motifs and shares a CXXC domain with DNA
methyltransferase, human trithorax, and methyl-CpG binding
domain protein 1. Mol. Cell. Biol., 20, 2108–2121.
46. Cho,Y.W., Hong,T., Hong,S., Guo,H., Yu,H., Kim,D.,
Guszczynski,T., Dressler,G.R., Copeland,T.D., Kalkum,M. et al.
(2007) PTIP associates with MLL3- and MLL4-containing histone
H3 lysine 4 methyltransferase complex. J. Biol. Chem., 282,
20395–20406.
47. Sze,C.C., Cao,K., Collings,C.K., Marshall,S.A., Rendleman,E.J.,
Ozark,P.A., Chen,F.X., Morgan,M.A., Wang,L. and Shilatifard,A.
(2017) Histone H3K4 methylation-dependent and -independent
functions of Set1A/COMPASS in embryonic stem cell self-renewal
and differentiation. Genes Dev., 31, 1732–1737.
48. Salz,T., Deng,C., Pampo,C., Siemann,D., Qiu,Y., Brown,K. and
Huang,S. (2015) Histone methyltransferase hSETD1A is a novel
regulator of metastasis in breast cancer. Mol. Cancer Res., 13,
461–469.
49. Tajima,K., Yae,T., Javaid,S., Tam,O., Comaills,V., Morris,R.,
Wittner,B.S., Liu,M., Engstrom,A., Takahashi,F. et al. (2015)
SETD1A modulates cell cycle progression through a miRNA
network that regulates p53 target genes. Nat. Commun., 6, 8257.
50. Bledau,A.S., Schmidt,K., Neumann,K., Hill,U., Ciotta,G., Gupta,A.,
Torres,D.C., Fu,J., Kranz,A., Stewart,A.F. et al. (2014) The H3K4
methyltransferase Setd1a is first required at the epiblast stage,
whereas Setd1b becomes essential after gastrulation. Development,
141, 1022–1035.
51. van Nuland,R., Smits,A.H., Pallaki,P., Jansen,P.W., Vermeulen,M.
and Timmers,H.T. (2013) Quantitative dissection and stoichiometry
determination of the human SET1/MLL histone methyltransferase
complexes. Mol. Cell. Biol., 33, 2067–2077.
52. Wang,L., Collings,C.K., Zhao,Z., Cozzolino,K.A., Ma,Q., Liang,K.,
Marshall,S.A., Sze,C.C., Hashizume,R., Savas,J.N. et al. (2017) A
cytoplasmic COMPASS is necessary for cell survival and
triple-negative breast cancer pathogenesis by regulating metabolism.
Genes Dev., 31, 2056–2066.
53. Weirich,S., Kudithipudi,S., Kycia,I. and Jeltsch,A. (2015) Somatic
cancer mutations in the MLL3-SET domain alter the catalytic
properties of the enzyme. Clin. Epigenet., 7, 36.
54. Takeda,S., Chen,D.Y., Westergard,T.D., Fisher,J.K., Rubens,J.A.,
Sasagawa,S., Kan,J.T., Korsmeyer,S.J., Cheng,E.H. and Hsieh,J.J.
(2006) Proteolysis of MLL family proteins is essential for
taspase1-orchestrated cell cycle progression. Genes Dev., 20,
2397–2409.
